NCT02068573

Brief Summary

AsthmaVent is a multi-center study, investigating the association between indoor air quality and childhood asthma. In Denmark, we spend more and more time indoors. Our houses are built airtight to save energy and are difficult to ventilate. We are thus more exposed to our indoor air than ever before. We know that indoor air contains many different components that can affect our airways inappropriately and particularly children with asthma, who have sensitive airways are sensitive to these components. The AsthmaVent project examines whether increased ventilation is able to improve the indoor environment to such an extent that the asthma disease control, for children with asthma and house dust mite allergy improves, resulting in need for less medication. Previous studies have pointed towards a beneficial effect of mechanical ventilation, on both the indoor air quality and on children's health and quality of life. There is not currently a consensus in this area, as studies so far have not been large or good enough to confidently determine the effect. This project is big and is designed so that it takes into account the sources of error seen in previous studies on the topic. We include, over a 3-year period (2012-2014), a total of 80 children with asthma and house dust mite allergy aged 6-18 years, from pediatric departments in Aarhus, Odense, Kolding, Randers and Herning. They are divided into two groups, receiving either active ventilation or placebo ventilation, meaning a non-functioning ventilation system that just recirculates the air in the room. Ventilation systems are installed in the fall and winter and ventilate the child's bedroom during 9 months. Indoor air quality and asthma control are assessed every 3 months, both at home visits were air quality and allergen levels of house dust mites are studies and at visits to the outpatient clinics with control of asthma parameters and quality of life. The project involves collaboration between several institutions with an interest in indoor air quality in relation to allergies and asthma and with great expertise in the field.The project was initiated by CISBO (Centre for Indoor Environment and Health in Dwellings), a center consisting of several institutions in Denmark dealing with indoor environment: Department of Public Health at Aarhus University and University of Copenhagen, Danish Building Research Institute and the Technical University of Denmark. Since asthma is the most common chronic childhood disease in Denmark and since the development of allergies and asthma has high social and personal costs, it is important for both society and the individual family, to find out whether simply improving the indoor air quality by increased ventilation can lead to an improvement in asthma disease control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2012

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

February 19, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 21, 2014

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2016

Completed
Last Updated

May 12, 2016

Status Verified

May 1, 2016

Enrollment Period

3.5 years

First QC Date

February 19, 2014

Last Update Submit

May 11, 2016

Conditions

Keywords

Childhood AsthmaAllergyHouse dust mitesIndoor air quality

Outcome Measures

Primary Outcomes (2)

  • Changes in dose of inhaled corticosteroid

    Measured in micrograms of a specific inhaled corticosteroid

    Baseline, 3 months, 6 months and 9 months

  • Changes in particle concentration in child bedroom

    Measured as particles pr. m3

    baseline, 3 months, 6 months and 9 months

Secondary Outcomes (9)

  • FEV1

    Baseline, 3,6 and 9 months

  • FeNO

    Baseline, 3,6 and 9 months

  • Quality of Life

    Baseline, 3,6 and 9 months

  • Standard Skin-prick-test and Specific IgE- phadiatop

    Baseline and 9 months

  • Asthma Symptoms

    During 14 days at baseline, 3, 6 and 9 months

  • +4 more secondary outcomes

Study Arms (2)

Ventilation

ACTIVE COMPARATOR

Increased ventilation in the childs bedroom to at least 2-3 air changes pr hour.

Device: Ventilation

Placebo ventilation

PLACEBO COMPARATOR

Ventilation system that recirculates the air in the childs bedroom

Device: Placebo Ventilation

Interventions

The ventilation system is placed outside the house and provides filtered conditioned air to the child's bedroom, through insulated pipes mounted in a window opening. The window opening was built specifically for this purpose in form of a thermo plate replacing the window glass. The unit provides the bedroom with at least 2-3 air changes per hour

Also known as: Ventilation units Type DUPLEX 370 EC4.D
Ventilation

The placebo unit (DUPLEX 370) is a completely similar installation to the active ventilation unit, but it only recirculates the air in the room instead of replacing it with fresh conditioned air.

Also known as: Placebo ventilation unit type DUPLEX 370
Placebo ventilation

Eligibility Criteria

Age5 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Doctors diagnosed asthma
  • Need of inhaled steroid titrated down to at least 400 microg/day of Budesonide or equivalent dose of other corticosteroid
  • Skin prick test \>/= 3 mm or specific IgE \>/= 0,7 kU/l to house dust mites (Derm. Pteronyssinus and/or Derm. Farinae)
  • more than 500 nanog/gr dust of house dust mite allergen in the childs mattress.
  • Living in a one-family house and will allow changes of the house during the intervention period.
  • Capable of giving informed consent.

You may not qualify if:

  • Other clinically relevant allergies to tree pollen or animals present in the house.
  • Other diseases or treatments, as for example immunotherapy, which could influence the results.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Børneafdelingen Herlev Hospital

Herlev, Capital Region, 2730, Denmark

Location

Childrens Department, Aarhus University Hospital

Aarhus, Region Midt, 8200, Denmark

Location

Childrens Department, Herning Hospital

Herning, Region Midt, 7400, Denmark

Location

Childrens DEpartment, Randers Hospital

Randers, Region Midt, 8930, Denmark

Location

Childrens Department, Hillerød hospital

Hillerød, Region Nordsjælland, 3400, Denmark

Location

Childrens Department, Kolding Hospital

Kolding, Region Syddanmark, 6000, Denmark

Location

H.C. Andersens Children Hospital, Odense University Hospital

Odense, Region Syddanmark, 5000, Denmark

Location

MeSH Terms

Conditions

Hypersensitivity

Condition Hierarchy (Ancestors)

Immune System Diseases

Study Officials

  • Torben Sigsgaard, Professor

    Aarhus University, Department of Public Health, Section for Environment, Occupation and Health

    STUDY DIRECTOR
  • Nina V Hogaard, MD

    Aarhus University, Dept. of Public Health, Section for Environment, Occupation and Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 19, 2014

First Posted

February 21, 2014

Study Start

August 1, 2012

Primary Completion

February 1, 2016

Study Completion

February 1, 2016

Last Updated

May 12, 2016

Record last verified: 2016-05

Locations